Back to Startups

Portal Biotech

About Portal Biotech

Portal Biotech is working to achieve full-length single-molecule protein sequencing, aiming to revolutionize the field of proteomics and metabolomics.

Business Information
Target Customers
biotech companies pharmaceutical companies academic institutions research organizations
Industry Categories
Bioscience & Disease Deep Tech Data, Analytics, Data Science
Business Model
Revenue Model B2B
Pricing Strategy Custom pricing based on services
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Series A Jul 04, 2025 $35.0M NATO Innovation Fund, Earlybird Venture Capital
Founders

No founder information available.

Investors
E
N
NATO Innovation Fund

Corporate Venture Capital

Recent Mentions
BIA_UK
BioIndustry Association (BIA) @BIA_UK
Jul 04, 2025

Another BIA member making waves in the #LifeSciences sector! Huge congratulations to Portal Biotech on their $35M Series A raise 👏 ➡️ https://t.co/glJzffVrXk Headquartered in #London, Portal Biotech is working to achieve full-length single-molecule protein sequencing, a https://t.co/v7m9ZY1UbD

Benzinga
Benzinga @Benzinga
Jul 18, 2025

NATO has made its first biotech investment by backing Portal Biotech, a U.K. startup developing AI-powered tools to detect biological threats. The $35 million Series A round was co-led by the NATO Innovation Fund and Earlybird Venture Capital. Portal claims it’s the first to https://t.co/7xU1UtJZIJ